Ignite Creation Date:
2025-12-24 @ 3:06 PM
Ignite Modification Date:
2026-01-06 @ 6:40 PM
Study NCT ID:
NCT00346359
Status:
COMPLETED
Last Update Posted:
2010-05-14
First Post:
2006-06-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2041.00
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |